English

EPIX Pharmaceuticals, Inc.

EDGAR

Quarterly report (10-Q) · filed 2009-05-11

55 filing records in this dataset, filed from 1997-03-27 to 2009-05-11. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

3.65 million USD

2009-03-31 · USD

Exact inputs and evidence

Revenue: 3648685 USD Source

Operating margin

-242.7%

2009-03-31 · %

Exact inputs and evidence

Operating Income: -8855213 USD Source
Revenue: 3648685 USD Source

Operating cash flow

-9.78 million USD

2009-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: -9783477 USD Source

Cash and cash equivalents: 14.7 million USD 2009-03-31 Source
Exact value

14733581 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

29.9 million USD

2008-04-01 – 2009-03-31

Exact inputs and evidence

Revenue: 17354995 USD · 2008-04-01 – 2008-06-30 Source
Revenue: 5100820 USD · 2008-07-01 – 2008-09-30 Source
Revenue: 28628355 USD · 2008-01-01 – 2008-12-31 Source
Revenue: 24864089 USD · 2008-01-01 – 2008-09-30 Source
Revenue: 3648685 USD · 2009-01-01 – 2009-03-31 Source

Net income

-32.7 million USD

2008-04-01 – 2009-03-31

Exact inputs and evidence

Net income: -2335964 USD · 2008-04-01 – 2008-06-30 Source
Net income: -10190643 USD · 2008-07-01 – 2008-09-30 Source
Net income: -36670989 USD · 2008-01-01 – 2008-12-31 Source
Net income: -26261093 USD · 2008-01-01 – 2008-09-30 Source
Net income: -9741956 USD · 2009-01-01 – 2009-03-31 Source

Operating cash flow

-31.7 million USD

2008-04-01 – 2009-03-31

Exact inputs and evidence

Operating cash flow: -17831025 USD · 2008-01-01 – 2008-06-30 Source
Operating cash flow: -14484540 USD · 2008-01-01 – 2008-03-31 Source
Operating cash flow: -26696998 USD · 2008-01-01 – 2008-09-30 Source
Operating cash flow: -17831025 USD · 2008-01-01 – 2008-06-30 Source
Operating cash flow: -36449225 USD · 2008-01-01 – 2008-12-31 Source
Operating cash flow: -26696998 USD · 2008-01-01 – 2008-09-30 Source
Operating cash flow: -9783477 USD · 2009-01-01 – 2009-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2009-05-11.

Financial data available through: 2008-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2008-12-31
Operating income: 11 of 11 periods available· newest 2008-12-31
Net income: 11 of 11 periods available· newest 2008-12-31
Operating cash flow: 11 of 11 periods available· newest 2008-12-31
capital expenditure: No compatible figures in this window
Total assets: 11 of 11 periods available· newest 2008-12-31
Total liabilities: 4 of 11 periods available· newest 2008-12-31
Current assets: 11 of 11 periods available· newest 2008-12-31
Current liabilities: 11 of 11 periods available· newest 2008-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2008-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+91.4%

Prior period

USD 14.96 million

2007-01-01 – 2007-12-31
Current period

USD 28.63 million

2008-01-01 – 2008-12-31

Exact inputs and evidence

28628355 − 14960049 = 13668306 USD

14960049 USD · 2007-01-01 – 2007-12-31
Inspect prior input Prior source
28628355 USD · 2008-01-01 – 2008-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · EPIX Pharmaceuticals, Inc. · 2008-12-31 EPIX Pharmaceuticals, Inc. (edgar:1027702) Year-over-year change in Revenue: 13668306 USD Concept: fundies:Revenue Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T13:51:19Z Snapshot: ca8ece048b76d8f77aa45ccea5f68e3d8fedd84a7804dd67b96c89aa9b1f8b75 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1027702?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 28628355 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1027702/0000950135-09-001716.txt#18983 Input fundies:Revenue: 14960049 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1027702/0000950135-09-001716.txt#18983
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 26.12 million

Prior period

−USD 62.79 million

2007-01-01 – 2007-12-31
Current period

−USD 36.67 million

2008-01-01 – 2008-12-31

Exact inputs and evidence

-36670989 − -62788563 = 26117574 USD

-62788563 USD · 2007-01-01 – 2007-12-31
Inspect prior input Prior source
-36670989 USD · 2008-01-01 – 2008-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · EPIX Pharmaceuticals, Inc. · 2008-12-31 EPIX Pharmaceuticals, Inc. (edgar:1027702) Year-over-year change in Net income: 26117574 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T13:51:19Z Snapshot: ca8ece048b76d8f77aa45ccea5f68e3d8fedd84a7804dd67b96c89aa9b1f8b75 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1027702?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -36670989 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1027702/0000950135-09-001716.txt#23212 Input fundies:NetIncome: -62788563 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1027702/0000950135-09-001716.txt#23212
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 20.69 million

Prior period

−USD 57.14 million

2007-01-01 – 2007-12-31
Current period

−USD 36.45 million

2008-01-01 – 2008-12-31

Exact inputs and evidence

-36449225 − -57138580 = 20689355 USD

-57138580 USD · 2007-01-01 – 2007-12-31
Inspect prior input Prior source
-36449225 USD · 2008-01-01 – 2008-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · EPIX Pharmaceuticals, Inc. · 2008-12-31 EPIX Pharmaceuticals, Inc. (edgar:1027702) Year-over-year change in Operating cash flow: 20689355 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T13:51:19Z Snapshot: ca8ece048b76d8f77aa45ccea5f68e3d8fedd84a7804dd67b96c89aa9b1f8b75 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1027702?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -36449225 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1027702/0000950135-09-001716.txt#24029 Input fundies:OperatingCashFlow: -57138580 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1027702/0000950135-09-001716.txt#24029
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2008 2008-01-01 – 2008-12-31

Revenue USD 28.63 million 100% of revenue
Operating costs Derived USD 62.87 million 220% of revenue
Operating income −USD 34.24 million −120% of revenue
Tax, interest and other Derived USD 2.43 million 8.5% of revenue
Net income −USD 36.67 million −128% of revenue

Cash

Operating cash flow −USD 36.45 million −127% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1999 Operating loss: operating costs were 1,668% of revenue.
2000 Operating loss: operating costs were 443% of revenue.
2001 Operating loss: operating costs were 297% of revenue.
2002 Operating loss: operating costs were 286% of revenue.
2003 Operating loss: operating costs were 256% of revenue.
2004 Operating loss: operating costs were 282% of revenue.
2005 Operating loss: operating costs were 403% of revenue.
2006 Operating loss: operating costs were 2,710% of revenue.
2007 Operating loss: operating costs were 525% of revenue.
2008 Operating loss: operating costs were 220% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1999 1999-01-01 – 1999-12-31	1144056	19078564 Derived	-17934508	-951355 Derived	-16983153	Unavailable	Source 1999-01-01 – 1999-12-31: 1144056 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -17934508 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: -16983153 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: -15748677 USD Inspect Operating Cash Flow Open source
2000 2000-01-01 – 2000-12-31	6923750	30668403 Derived	-23744653	3575590 Derived	-27320243	Unavailable	Source 2000-01-01 – 2000-12-31: 6923750 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -23744653 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: -27320243 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: -12834922 USD Inspect Operating Cash Flow Open source
2001 2001-01-01 – 2001-12-31	9568715	28409587 Derived	-18840872	407151 Derived	-19248023	Unavailable	Source 2001-01-01 – 2001-12-31: 9568715 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -18840872 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: -19248023 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: -7601117 USD Inspect Operating Cash Flow Open source
2002 2002-01-01 – 2002-12-31	12269501	35085568 Derived	-22816067	-624846 Derived	-22191221	Unavailable	Source 2002-01-01 – 2002-12-31: 12269501 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -22816067 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -22191221 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -23995454 USD Inspect Operating Cash Flow Open source
2003 2003-01-01 – 2003-12-31	13525012	34607840 Derived	-21082828	-288276 Derived	-20794552	Unavailable	Source 2003-01-01 – 2003-12-31: 13525012 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -21082828 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -20794552 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -23959560 USD Inspect Operating Cash Flow Open source
2004 2004-01-01 – 2004-12-31	12258601	34609332 Derived	-22350731	270491 Derived	-22621222	Unavailable	Source 2004-01-01 – 2004-12-31: 12258601 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -22350731 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -22621222 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -22460817 USD Inspect Operating Cash Flow Open source
2005 2005-01-01 – 2005-12-31	7189661	28949970 Derived	-21760309	-491351 Derived	-21268958	Unavailable	Source 2005-01-01 – 2005-12-31: 7189661 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -21760309 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -21268958 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -23723992 USD Inspect Operating Cash Flow Open source
2006 2006-01-01 – 2006-12-31	6040542	163708660 Derived	-157668118	-274920 Derived	-157393198	Unavailable	Source 2006-01-01 – 2006-12-31: 6040542 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -157668118 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -157393198 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -15639045 USD Inspect Operating Cash Flow Open source
2007 2007-01-01 – 2007-12-31	14960049	78523805 Derived	-63563756	-775193 Derived	-62788563	Unavailable	Source 2007-01-01 – 2007-12-31: 14960049 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -63563756 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -62788563 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: -57138580 USD Inspect Operating Cash Flow Open source
2008 2008-01-01 – 2008-12-31	28628355	62869033 Derived	-34240678	2430311 Derived	-36670989	Unavailable	Source 2008-01-01 – 2008-12-31: 28628355 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -34240678 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -36670989 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: -36449225 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 28.6M 2008

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19991999-12-31	Revenue	1144056	Revenue: 1144056 Open source
20002000-12-31	Revenue	6923750	Revenue: 6923750 Open source
20012001-12-31	Revenue	9568715	Revenue: 9568715 Open source
20022002-12-31	Revenue	12269501	Revenue: 12269501 Open source
20032003-12-31	Revenue	13525012	Revenue: 13525012 Open source
20042004-12-31	Revenue	12258601	Revenue: 12258601 Open source
20052005-12-31	Revenue	7189661	Revenue: 7189661 Open source
20062006-12-31	Revenue	6040542	Revenue: 6040542 Open source
20072007-12-31	Revenue	14960049	Revenue: 14960049 Open source
20082008-12-31	Revenue	28628355	Revenue: 28628355 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

91.4% 2008

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19991999-12-31	Year over year	-35.8%	Revenue: 1144056 Open source Revenue: 1780985 Open source
20002000-12-31	Year over year	505.2%	Revenue: 6923750 Open source Revenue: 1144056 Open source
20012001-12-31	Year over year	38.2%	Revenue: 9568715 Open source Revenue: 6923750 Open source
20022002-12-31	Year over year	28.2%	Revenue: 12269501 Open source Revenue: 9568715 Open source
20032003-12-31	Year over year	10.2%	Revenue: 13525012 Open source Revenue: 12269501 Open source
20042004-12-31	Year over year	-9.4%	Revenue: 12258601 Open source Revenue: 13525012 Open source
20052005-12-31	Year over year	-41.4%	Revenue: 7189661 Open source Revenue: 12258601 Open source
20062006-12-31	Year over year	-16%	Revenue: 6040542 Open source Revenue: 7189661 Open source
20072007-12-31	Year over year	147.7%	Revenue: 14960049 Open source Revenue: 6040542 Open source
20082008-12-31	Year over year	91.4%	Revenue: 28628355 Open source Revenue: 14960049 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -119.6% 2008

Net margin -128.1% 2008

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19991999-12-31	Operating margin	-1,567.6%	Operating Income: -17934508 Open source Revenue: 1144056 Open source
20002000-12-31	Operating margin	-342.9%	Operating Income: -23744653 Open source Revenue: 6923750 Open source
20012001-12-31	Operating margin	-196.9%	Operating Income: -18840872 Open source Revenue: 9568715 Open source
20022002-12-31	Operating margin	-186%	Operating Income: -22816067 Open source Revenue: 12269501 Open source
20032003-12-31	Operating margin	-155.9%	Operating Income: -21082828 Open source Revenue: 13525012 Open source
20042004-12-31	Operating margin	-182.3%	Operating Income: -22350731 Open source Revenue: 12258601 Open source
20052005-12-31	Operating margin	-302.7%	Operating Income: -21760309 Open source Revenue: 7189661 Open source
20062006-12-31	Operating margin	-2,610.2%	Operating Income: -157668118 Open source Revenue: 6040542 Open source
20072007-12-31	Operating margin	-424.9%	Operating Income: -63563756 Open source Revenue: 14960049 Open source
20082008-12-31	Operating margin	-119.6%	Operating Income: -34240678 Open source Revenue: 28628355 Open source
19991999-12-31	Net margin	-1,484.5%	Net Income: -16983153 Open source Revenue: 1144056 Open source
20002000-12-31	Net margin	-394.6%	Net Income: -27320243 Open source Revenue: 6923750 Open source
20012001-12-31	Net margin	-201.2%	Net Income: -19248023 Open source Revenue: 9568715 Open source
20022002-12-31	Net margin	-180.9%	Net Income: -22191221 Open source Revenue: 12269501 Open source
20032003-12-31	Net margin	-153.7%	Net Income: -20794552 Open source Revenue: 13525012 Open source
20042004-12-31	Net margin	-184.5%	Net Income: -22621222 Open source Revenue: 12258601 Open source
20052005-12-31	Net margin	-295.8%	Net Income: -21268958 Open source Revenue: 7189661 Open source
20062006-12-31	Net margin	-2,605.6%	Net Income: -157393198 Open source Revenue: 6040542 Open source
20072007-12-31	Net margin	-419.7%	Net Income: -62788563 Open source Revenue: 14960049 Open source
20082008-12-31	Net margin	-128.1%	Net Income: -36670989 Open source Revenue: 28628355 Open source
19991999-12-31	Free cash flow margin	Not reported	Revenue: 1144056 Open source Operating Cash Flow: -15748677 Open source
20002000-12-31	Free cash flow margin	Not reported	Revenue: 6923750 Open source Operating Cash Flow: -12834922 Open source
20012001-12-31	Free cash flow margin	Not reported	Revenue: 9568715 Open source Operating Cash Flow: -7601117 Open source
20022002-12-31	Free cash flow margin	Not reported	Revenue: 12269501 Open source Operating Cash Flow: -23995454 Open source
20032003-12-31	Free cash flow margin	Not reported	Revenue: 13525012 Open source Operating Cash Flow: -23959560 Open source
20042004-12-31	Free cash flow margin	Not reported	Revenue: 12258601 Open source Operating Cash Flow: -22460817 Open source
20052005-12-31	Free cash flow margin	Not reported	Revenue: 7189661 Open source Operating Cash Flow: -23723992 Open source
20062006-12-31	Free cash flow margin	Not reported	Revenue: 6040542 Open source Operating Cash Flow: -15639045 Open source
20072007-12-31	Free cash flow margin	Not reported	Revenue: 14960049 Open source Operating Cash Flow: -57138580 Open source
20082008-12-31	Free cash flow margin	Not reported	Revenue: 28628355 Open source Operating Cash Flow: -36449225 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -36.4M 2008

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19991999-12-31	Operating cash flow	-15748677	Operating Cash Flow: -15748677 Open source
20002000-12-31	Operating cash flow	-12834922	Operating Cash Flow: -12834922 Open source
20012001-12-31	Operating cash flow	-7601117	Operating Cash Flow: -7601117 Open source
20022002-12-31	Operating cash flow	-23995454	Operating Cash Flow: -23995454 Open source
20032003-12-31	Operating cash flow	-23959560	Operating Cash Flow: -23959560 Open source
20042004-12-31	Operating cash flow	-22460817	Operating Cash Flow: -22460817 Open source
20052005-12-31	Operating cash flow	-23723992	Operating Cash Flow: -23723992 Open source
20062006-12-31	Operating cash flow	-15639045	Operating Cash Flow: -15639045 Open source
20072007-12-31	Operating cash flow	-57138580	Operating Cash Flow: -57138580 Open source
20082008-12-31	Operating cash flow	-36449225	Operating Cash Flow: -36449225 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19991999-12-31	Free cash flow	Unavailable	Operating Cash Flow: -15748677 Open source
20002000-12-31	Free cash flow	Unavailable	Operating Cash Flow: -12834922 Open source
20012001-12-31	Free cash flow	Unavailable	Operating Cash Flow: -7601117 Open source
20022002-12-31	Free cash flow	Unavailable	Operating Cash Flow: -23995454 Open source
20032003-12-31	Free cash flow	Unavailable	Operating Cash Flow: -23959560 Open source
20042004-12-31	Free cash flow	Unavailable	Operating Cash Flow: -22460817 Open source
20052005-12-31	Free cash flow	Unavailable	Operating Cash Flow: -23723992 Open source
20062006-12-31	Free cash flow	Unavailable	Operating Cash Flow: -15639045 Open source
20072007-12-31	Free cash flow	Unavailable	Operating Cash Flow: -57138580 Open source
20082008-12-31	Free cash flow	Unavailable	Operating Cash Flow: -36449225 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

329.1% 2008

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1999-12-31	Liabilities / assets	Not reported	Total Assets: 17885583 Open source
2000-12-31	Liabilities / assets	Not reported	Total Assets: 29680587 Open source
2001-12-31	Liabilities / assets	Not reported	Total Assets: 26910693 Open source
2002-12-31	Liabilities / assets	Not reported	Total Assets: 30155230 Open source
2003-12-31	Liabilities / assets	Not reported	Total Assets: 81874730 Open source
2004-12-31	Liabilities / assets	Not reported	Total Assets: 171286926 Open source
20052005-12-31	Liabilities / assets	87%	Total Liabilities: 113768422 Open source Total Assets: 130715716 Open source
20062006-12-31	Liabilities / assets	125.6%	Total Liabilities: 157048773 Open source Total Assets: 125027492 Open source
20072007-12-31	Liabilities / assets	178.5%	Total Liabilities: 139366774 Open source Total Assets: 78075127 Open source
20082008-12-31	Liabilities / assets	329.1%	Total Liabilities: 135160529 Open source Total Assets: 41069459 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.64× 2008

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19991999-12-31	Current assets / current liabilities	3.17×	Current Assets: 15355033 Open source Current Liabilities: 4840566 Open source
20002000-12-31	Current assets / current liabilities	2.15×	Current Assets: 28084192 Open source Current Liabilities: 13064219 Open source
20012001-12-31	Current assets / current liabilities	1.48×	Current Assets: 25554318 Open source Current Liabilities: 17277549 Open source
20022002-12-31	Current assets / current liabilities	1.75×	Current Assets: 28803340 Open source Current Liabilities: 16439686 Open source
20032003-12-31	Current assets / current liabilities	3.44×	Current Assets: 80397983 Open source Current Liabilities: 23387360 Open source
20042004-12-31	Current assets / current liabilities	5.76×	Current Assets: 165347852 Open source Current Liabilities: 28695227 Open source
20052005-12-31	Current assets / current liabilities	9.62×	Current Assets: 125224702 Open source Current Liabilities: 13012775 Open source
20062006-12-31	Current assets / current liabilities	3.03×	Current Assets: 112164530 Open source Current Liabilities: 36982633 Open source
20072007-12-31	Current assets / current liabilities	3.41×	Current Assets: 63239996 Open source Current Liabilities: 18520607 Open source
20082008-12-31	Current assets / current liabilities	1.64×	Current Assets: 27773104 Open source Current Liabilities: 16884492 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1999 1999-01-01 – 1999-12-31	−USD 16.98 million Exact value Exact value: -16983153 USD 1999-01-01 – 1999-12-31: -16983153 USD Inspect Net Income Open source Share or cite Citation for Net Income · EPIX Pharmaceuticals, Inc. · 1999-12-31 EPIX Pharmaceuticals, Inc. (edgar:1027702) Net Income: -16983153 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T13:51:19Z Snapshot: ca8ece048b76d8f77aa45ccea5f68e3d8fedd84a7804dd67b96c89aa9b1f8b75 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1027702/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16983153 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1027702/0000912057-02-012472.txt#5705 The citation records this snapshot. The page link may show a newer release later.	−USD 15.75 million Exact value Exact value: -15748677 USD 1999-01-01 – 1999-12-31: -15748677 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EPIX Pharmaceuticals, Inc. · 1999-12-31 EPIX Pharmaceuticals, Inc. (edgar:1027702) Operating Cash Flow: -15748677 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T13:51:19Z Snapshot: ca8ece048b76d8f77aa45ccea5f68e3d8fedd84a7804dd67b96c89aa9b1f8b75 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1027702/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15748677 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1027702/0000912057-02-012472.txt#5979 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2000 2000-01-01 – 2000-12-31	−USD 27.32 million Exact value Exact value: -27320243 USD 2000-01-01 – 2000-12-31: -27320243 USD Inspect Net Income Open source Share or cite Citation for Net Income · EPIX Pharmaceuticals, Inc. · 2000-12-31 EPIX Pharmaceuticals, Inc. (edgar:1027702) Net Income: -27320243 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T13:51:19Z Snapshot: ca8ece048b76d8f77aa45ccea5f68e3d8fedd84a7804dd67b96c89aa9b1f8b75 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1027702/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -27320243 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1027702/0001047469-03-010954.txt#5819 The citation records this snapshot. The page link may show a newer release later.	−USD 12.83 million Exact value Exact value: -12834922 USD 2000-01-01 – 2000-12-31: -12834922 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EPIX Pharmaceuticals, Inc. · 2000-12-31 EPIX Pharmaceuticals, Inc. (edgar:1027702) Operating Cash Flow: -12834922 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T13:51:19Z Snapshot: ca8ece048b76d8f77aa45ccea5f68e3d8fedd84a7804dd67b96c89aa9b1f8b75 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1027702/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -12834922 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1027702/0001047469-03-010954.txt#6079 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2001 2001-01-01 – 2001-12-31	−USD 19.25 million Exact value Exact value: -19248023 USD 2001-01-01 – 2001-12-31: -19248023 USD Inspect Net Income Open source Share or cite Citation for Net Income · EPIX Pharmaceuticals, Inc. · 2001-12-31 EPIX Pharmaceuticals, Inc. (edgar:1027702) Net Income: -19248023 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T13:51:19Z Snapshot: ca8ece048b76d8f77aa45ccea5f68e3d8fedd84a7804dd67b96c89aa9b1f8b75 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1027702/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -19248023 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1027702/0001047469-04-006947.txt#5776 The citation records this snapshot. The page link may show a newer release later.	−USD 7.6 million Exact value Exact value: -7601117 USD 2001-01-01 – 2001-12-31: -7601117 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EPIX Pharmaceuticals, Inc. · 2001-12-31 EPIX Pharmaceuticals, Inc. (edgar:1027702) Operating Cash Flow: -7601117 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T13:51:19Z Snapshot: ca8ece048b76d8f77aa45ccea5f68e3d8fedd84a7804dd67b96c89aa9b1f8b75 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1027702/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7601117 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1027702/0001047469-04-006947.txt#5980 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2002 2002-01-01 – 2002-12-31	−USD 22.19 million Exact value Exact value: -22191221 USD 2002-01-01 – 2002-12-31: -22191221 USD Inspect Net Income Open source Share or cite Citation for Net Income · EPIX Pharmaceuticals, Inc. · 2002-12-31 EPIX Pharmaceuticals, Inc. (edgar:1027702) Net Income: -22191221 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T13:51:19Z Snapshot: ca8ece048b76d8f77aa45ccea5f68e3d8fedd84a7804dd67b96c89aa9b1f8b75 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1027702/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -22191221 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1027702/0001047469-05-006198.txt#6265 The citation records this snapshot. The page link may show a newer release later.	−USD 24 million Exact value Exact value: -23995454 USD 2002-01-01 – 2002-12-31: -23995454 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EPIX Pharmaceuticals, Inc. · 2002-12-31 EPIX Pharmaceuticals, Inc. (edgar:1027702) Operating Cash Flow: -23995454 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T13:51:19Z Snapshot: ca8ece048b76d8f77aa45ccea5f68e3d8fedd84a7804dd67b96c89aa9b1f8b75 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1027702/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -23995454 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1027702/0001047469-05-006198.txt#6469 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2003 2003-01-01 – 2003-12-31	−USD 20.79 million Exact value Exact value: -20794552 USD 2003-01-01 – 2003-12-31: -20794552 USD Inspect Net Income Open source Share or cite Citation for Net Income · EPIX Pharmaceuticals, Inc. · 2003-12-31 EPIX Pharmaceuticals, Inc. (edgar:1027702) Net Income: -20794552 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T13:51:19Z Snapshot: ca8ece048b76d8f77aa45ccea5f68e3d8fedd84a7804dd67b96c89aa9b1f8b75 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1027702/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -20794552 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1027702/0000950135-06-001276.txt#11493 The citation records this snapshot. The page link may show a newer release later.	−USD 23.96 million Exact value Exact value: -23959560 USD 2003-01-01 – 2003-12-31: -23959560 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EPIX Pharmaceuticals, Inc. · 2003-12-31 EPIX Pharmaceuticals, Inc. (edgar:1027702) Operating Cash Flow: -23959560 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T13:51:19Z Snapshot: ca8ece048b76d8f77aa45ccea5f68e3d8fedd84a7804dd67b96c89aa9b1f8b75 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1027702/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -23959560 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1027702/0000950135-06-001276.txt#11786 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2004 2004-01-01 – 2004-12-31	−USD 22.62 million Exact value Exact value: -22621222 USD 2004-01-01 – 2004-12-31: -22621222 USD Inspect Net Income Open source Share or cite Citation for Net Income · EPIX Pharmaceuticals, Inc. · 2004-12-31 EPIX Pharmaceuticals, Inc. (edgar:1027702) Net Income: -22621222 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T13:51:19Z Snapshot: ca8ece048b76d8f77aa45ccea5f68e3d8fedd84a7804dd67b96c89aa9b1f8b75 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1027702/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -22621222 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1027702/0000950135-07-002173.txt#37890 The citation records this snapshot. The page link may show a newer release later.	−USD 22.46 million Exact value Exact value: -22460817 USD 2004-01-01 – 2004-12-31: -22460817 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EPIX Pharmaceuticals, Inc. · 2004-12-31 EPIX Pharmaceuticals, Inc. (edgar:1027702) Operating Cash Flow: -22460817 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T13:51:19Z Snapshot: ca8ece048b76d8f77aa45ccea5f68e3d8fedd84a7804dd67b96c89aa9b1f8b75 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1027702/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -22460817 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1027702/0000950135-07-002173.txt#38643 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2005 2005-01-01 – 2005-12-31	−USD 21.27 million Exact value Exact value: -21268958 USD 2005-01-01 – 2005-12-31: -21268958 USD Inspect Net Income Open source Share or cite Citation for Net Income · EPIX Pharmaceuticals, Inc. · 2005-12-31 EPIX Pharmaceuticals, Inc. (edgar:1027702) Net Income: -21268958 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T13:51:19Z Snapshot: ca8ece048b76d8f77aa45ccea5f68e3d8fedd84a7804dd67b96c89aa9b1f8b75 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1027702/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -21268958 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1027702/0000950135-08-001816.txt#23592 The citation records this snapshot. The page link may show a newer release later.	−USD 23.72 million Exact value Exact value: -23723992 USD 2005-01-01 – 2005-12-31: -23723992 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EPIX Pharmaceuticals, Inc. · 2005-12-31 EPIX Pharmaceuticals, Inc. (edgar:1027702) Operating Cash Flow: -23723992 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T13:51:19Z Snapshot: ca8ece048b76d8f77aa45ccea5f68e3d8fedd84a7804dd67b96c89aa9b1f8b75 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1027702/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -23723992 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1027702/0000950135-08-001816.txt#24409 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2006 2006-01-01 – 2006-12-31	−USD 157.39 million Exact value Exact value: -157393198 USD 2006-01-01 – 2006-12-31: -157393198 USD Inspect Net Income Open source Share or cite Citation for Net Income · EPIX Pharmaceuticals, Inc. · 2006-12-31 EPIX Pharmaceuticals, Inc. (edgar:1027702) Net Income: -157393198 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T13:51:19Z Snapshot: ca8ece048b76d8f77aa45ccea5f68e3d8fedd84a7804dd67b96c89aa9b1f8b75 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1027702/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -157393198 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1027702/0000950135-09-001716.txt#23212 The citation records this snapshot. The page link may show a newer release later.	−USD 15.64 million Exact value Exact value: -15639045 USD 2006-01-01 – 2006-12-31: -15639045 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EPIX Pharmaceuticals, Inc. · 2006-12-31 EPIX Pharmaceuticals, Inc. (edgar:1027702) Operating Cash Flow: -15639045 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T13:51:19Z Snapshot: ca8ece048b76d8f77aa45ccea5f68e3d8fedd84a7804dd67b96c89aa9b1f8b75 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1027702/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15639045 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1027702/0000950135-09-001716.txt#24029 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2007 2007-01-01 – 2007-12-31	−USD 62.79 million Exact value Exact value: -62788563 USD 2007-01-01 – 2007-12-31: -62788563 USD Inspect Net Income Open source Share or cite Citation for Net Income · EPIX Pharmaceuticals, Inc. · 2007-12-31 EPIX Pharmaceuticals, Inc. (edgar:1027702) Net Income: -62788563 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T13:51:19Z Snapshot: ca8ece048b76d8f77aa45ccea5f68e3d8fedd84a7804dd67b96c89aa9b1f8b75 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1027702/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -62788563 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1027702/0000950135-09-001716.txt#23212 The citation records this snapshot. The page link may show a newer release later.	−USD 57.14 million Exact value Exact value: -57138580 USD 2007-01-01 – 2007-12-31: -57138580 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EPIX Pharmaceuticals, Inc. · 2007-12-31 EPIX Pharmaceuticals, Inc. (edgar:1027702) Operating Cash Flow: -57138580 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T13:51:19Z Snapshot: ca8ece048b76d8f77aa45ccea5f68e3d8fedd84a7804dd67b96c89aa9b1f8b75 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1027702/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -57138580 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1027702/0000950135-09-001716.txt#24029 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2008 2008-01-01 – 2008-12-31	−USD 36.67 million Exact value Exact value: -36670989 USD 2008-01-01 – 2008-12-31: -36670989 USD Inspect Net Income Open source Share or cite Citation for Net Income · EPIX Pharmaceuticals, Inc. · 2008-12-31 EPIX Pharmaceuticals, Inc. (edgar:1027702) Net Income: -36670989 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T13:51:19Z Snapshot: ca8ece048b76d8f77aa45ccea5f68e3d8fedd84a7804dd67b96c89aa9b1f8b75 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1027702/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -36670989 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1027702/0000950135-09-001716.txt#23212 The citation records this snapshot. The page link may show a newer release later.	−USD 36.45 million Exact value Exact value: -36449225 USD 2008-01-01 – 2008-12-31: -36449225 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EPIX Pharmaceuticals, Inc. · 2008-12-31 EPIX Pharmaceuticals, Inc. (edgar:1027702) Operating Cash Flow: -36449225 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T13:51:19Z Snapshot: ca8ece048b76d8f77aa45ccea5f68e3d8fedd84a7804dd67b96c89aa9b1f8b75 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1027702/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -36449225 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1027702/0000950135-09-001716.txt#24029 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

55 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001027702, 1027702, edgar:1027702

Also known as EPIX MEDICAL INC

EPIX Pharmaceuticals, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2008 2008-01-01 – 2008-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation